When HIV pays the price: Fitness costs behind lenacapavir resistance.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 41499521.
- Also identified by DOI 10.1126/scitranslmed.aed6475.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
HIV can take several mutational pathways to become resistant to lenacapavir, each with distinct resistance and fitness profiles (Pennetzdorfer <i>et al.</i>, this issue).
Medical subject headings
- Anti-HIV Agents
- Drug Resistance, Viral
- HIV
- HIV-1